HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kimiyoshi Arimura Selected Research

Member 10c Tumor Necrosis Factor Receptors

9/2008Notice of retraction: Increased expression of TRAIL receptor 3 on eosinophils in Churg-Strauss syndrome (Arthritis Rheum 2007;56:662-73).
2/2007Increased expression of TRAIL receptor 3 on eosinophils in Churg-Strauss syndrome.
7/2004TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kimiyoshi Arimura Research Topics

Disease

9Tropical Spastic Paraparesis (Tropical Spastic Paraplegia)
02/2009 - 04/2004
7Isaacs Syndrome (Neuromyotonia)
12/2018 - 01/2002
6POEMS Syndrome (Syndrome, POEMS)
12/2013 - 12/2003
5Channelopathies
01/2012 - 01/2002
5Neoplasms (Cancer)
11/2009 - 10/2002
5Pneumonia (Pneumonitis)
11/2008 - 02/2006
4Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
02/2009 - 01/2002
4Churg-Strauss Syndrome (Allergic Angiitis)
09/2008 - 02/2006
4Spinal Cord Diseases
03/2008 - 10/2004
4Chronic Obstructive Pulmonary Disease (COPD)
01/2008 - 12/2005
3Thymoma (Thymic Carcinoma)
12/2018 - 12/2006
3Guillain-Barre Syndrome
01/2015 - 06/2008
3Nervous System Diseases (Neurological Disorders)
04/2013 - 06/2008
3Fibrosis (Cirrhosis)
11/2008 - 02/2006
3Asthma (Bronchial Asthma)
04/2007 - 02/2006
3Vasculitis (Vasculitides)
10/2006 - 12/2004
3Idiopathic Pulmonary Fibrosis
03/2006 - 05/2005
2Pain (Aches)
01/2020 - 12/2018
2Inclusion Body Myositis
08/2012 - 01/2008
2Myositis (Idiopathic Inflammatory Myopathies)
08/2012 - 09/2011
2Plasmacytoma
06/2012 - 10/2008
2Paralysis (Palsy)
01/2012 - 12/2007
2Myasthenia Gravis
09/2011 - 12/2007
2Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)
04/2010 - 12/2006
2Disseminated Intravascular Coagulation
11/2009 - 12/2003
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2008 - 07/2004
2Neutropenia
10/2008 - 07/2004
2Polyneuropathies (Polyneuropathy)
06/2008 - 05/2006
2Disease Progression
12/2007 - 08/2007
2Lung Diseases (Lung Disease)
06/2007 - 05/2005
2Pulmonary Fibrosis (Fibrosing Alveolitis)
05/2007 - 02/2006
2Infections
01/2007 - 10/2004
2Systemic Vasculitis
10/2006 - 02/2006
1Neuralgia (Stump Neuralgia)
01/2020
1Dystonia (Limb Dystonia)
01/2020
1Glioma (Gliomas)
12/2018
1Diabetic Neuropathies (Diabetic Neuropathy)
11/2014
1Diabetic Angiopathies (Diabetic Angiopathy)
11/2014
1Peripheral Nervous System Diseases (PNS Diseases)
01/2014
1Peripheral Nerve Injuries
01/2014
1Inflammation (Inflammations)
04/2013
1Virus Diseases (Viral Diseases)
04/2013
1Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic)
08/2012
1Polymyositis
09/2011
1Muscular Diseases (Myopathy)
09/2011
1Myotoxicity
09/2011
1Mitochondrial Diseases (Mitochondrial Disease)
09/2011
1Metachromatic Leukodystrophy (Sulfatide Lipidosis)
02/2011
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
02/2011
1Epilepsy (Aura)
04/2010
1T-Cell Leukemia (Leukemia, T Cell)
02/2009
1Arthritis (Polyarthritis)
09/2008
1Demyelinating Diseases (Demyelinating Disease)
06/2008

Drug/Important Bio-Agent (IBA)

11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2013 - 05/2002
8AntibodiesIBA
12/2018 - 09/2004
7Discoidin Domain Receptor 1IBA
11/2008 - 05/2005
5Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA
12/2018 - 09/2004
4Proteins (Proteins, Gene)FDA Link
12/2018 - 06/2008
4CytokinesIBA
06/2008 - 10/2002
4Tiotropium Bromide (Spiriva)FDA Link
01/2008 - 05/2006
4Pharmaceutical PreparationsIBA
08/2007 - 05/2006
3AutoantibodiesIBA
12/2018 - 06/2008
3Bleomycin (Blenoxane)FDA LinkGeneric
11/2008 - 02/2006
3Member 10c Tumor Necrosis Factor ReceptorsIBA
09/2008 - 07/2004
3oxitropium (oxitropium bromide)IBA
01/2008 - 05/2006
3Adrenal Cortex Hormones (Corticosteroids)IBA
08/2007 - 05/2006
3PotassiumIBA
01/2006 - 01/2002
2AntigensIBA
12/2018 - 05/2002
2GangliosidesIBA
04/2013 - 06/2008
2Mitochondrial DNA (mtDNA)IBA
09/2011 - 06/2002
2Potassium Channels (Potassium Channel)IBA
04/2010 - 01/2002
2Dacarbazine (DIC)FDA LinkGeneric
11/2009 - 12/2003
2ChemokinesIBA
11/2008 - 05/2005
2plerixaforFDA Link
11/2008 - 05/2007
2TNF-Related Apoptosis-Inducing LigandIBA
10/2008 - 07/2004
2Interferon-alpha (Interferon Alfa)IBA
08/2007 - 07/2006
2Bronchodilator Agents (Bronchodilators)IBA
01/2007 - 05/2006
2CollagenIBA
03/2006 - 05/2005
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
12/2005 - 11/2004
1incobotulinumtoxinAFDA Link
01/2020
1Type A Botulinum Toxins (Botox)FDA Link
01/2020
1Botulinum Toxins (Botulinum Toxin)IBA
01/2020
1Leucine (L-Leucine)FDA Link
12/2018
1Contactin 2IBA
12/2018
1Amantadine (Aman)FDA LinkGeneric
01/2015
1NAD (NADH)IBA
11/2014
1mecobalamin (methylcobalamin)IBA
01/2014
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
01/2014
1Carrier Proteins (Binding Protein)IBA
08/2012
1Myosins (Myosin)IBA
08/2012
1Amyloid (Amyloid Fibrils)IBA
08/2012
1Ion Channels (Ion Channel)IBA
01/2012
1Creatine Kinase (Creatine Phosphokinase)IBA
09/2011
1Cerebroside-Sulfatase (Arylsulfatase A)IBA
02/2011
1Peptide Hydrolases (Proteases)FDA Link
11/2009
1Messenger RNA (mRNA)IBA
02/2009
1lipid-linked oligosaccharidesIBA
06/2008

Therapy/Procedure

5Therapeutics
01/2014 - 07/2006
1Injections
01/2020
1Lasers (Laser)
11/2009